(Q40756554)

23 September 2017

Podocyte injury promotes progressive nephropathy in zucker diabetic fatty rats (English)

1 reference

23 September 2017

1 reference

Sachi Hoshi

1

1 reference

23 September 2017

Yujing Shu

2

1 reference

23 September 2017

Fusayo Yoshida

3

1 reference

23 September 2017

Tomoko Inagaki

4

1 reference

23 September 2017

Jiro Sonoda

5

1 reference

23 September 2017

Teruo Watanabe

6

1 reference

23 September 2017

Ken-ichi Nomoto

7

1 reference

23 September 2017

Michio Nagata

8

1 reference

23 September 2017

1 January 2002

1 reference

23 September 2017

Laboratory Investigation

1 reference

23 September 2017

82

1 reference

23 September 2017

25-35

1 reference

23 September 2017

1

1 reference

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

23 September 2017

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780392

7 January 2021

Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists. A novel treatment strategy

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780392

7 January 2021

Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780392

7 January 2021

Lipogenesis in situ in the genetically obese Zucker fatty rat (fa/fa): Role of hyperphagia and hyperinsulinaemia

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780392

7 January 2021

Laboratory animals exhibiting obesity and diabetes syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780392

7 January 2021

A new genetically obese-hyperglycemic rat (Wistar fatty)

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780392

7 January 2021

Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780392

7 January 2021

A role for podocytes to counteract capillary wall distension

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780392

7 January 2021

Long-term treatment of rats with FGF-2 results in focal segmental glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780392

7 January 2021

Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780392

7 January 2021

Glomerular damage after uninephrectomy in young rats. II. Mechanical stress on podocytes as a pathway to sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780392

7 January 2021

Cell cycle regulation and differentiation in the human podocyte lineage

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780392

7 January 2021

Studies on a diabetic (KK) strain of the mouse.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780392

7 January 2021

Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780392

7 January 2021

Urinary excretion of podocytes in patients with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780392

7 January 2021

Glomerular expression of cell-cycle-regulatory proteins in human crescentic glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780392

7 January 2021

The cyclin-dependent kinase inhibitor p27Kip1 safeguards against inflammatory injury

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780392

7 January 2021

Podocyte loss and progressive glomerular injury in type II diabetes

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780392

7 January 2021

Progression of diabetic nephropathy. Insights from cell culture studies and animal models

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780392

7 January 2021

Diabetic nephropathy in type II diabetes

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780392

7 January 2021

Cyclin kinase inhibitors are increased during experimental membranous nephropathy: potential role in limiting glomerular epithelial cell proliferation in vivo

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780392

7 January 2021

Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780392

7 January 2021

Characteristics of diabetes, blood pressure, and cardiac and renal complications in Otsuka Long-Evans Tokushima Fatty rats

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780392

7 January 2021

10.1038/LABINVEST.3780392

Identifiers

DOI

0 references

1 reference